Keyword: Allergan

Executive looking out window

W. Carl Reichel

The Department of Justice charged the pharmaceutical executive with fraud in November 2015, alleging that W. Carl Reichel conspired to pay kickbacks to physicians in exchange for prescribing the company’s drugs.